Back to Journals » Drug Design, Development and Therapy » Volume 9

Preparation and clinical evaluation of nano-transferosomes for treatment of erectile dysfunction

Authors Ali MFM, Salem HF, Abdelmohsen HF, Attia SK

Received 20 January 2015

Accepted for publication 2 March 2015

Published 29 April 2015 Volume 2015:9 Pages 2431—2447

DOI https://doi.org/10.2147/DDDT.S81236

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 4

Editor who approved publication: Professor Shu-Feng Zhou

Maha Fadel M Ali,1 Heba F Salem,2 Hany F Abdelmohsen,3 Sameh K Attia4

1Pharmaceutical Technology Unit, Medical Applications of Lasers Department, National Institute of Laser Enhanced Science, Cairo University, Cairo, Egypt; 2Pharmaceutics and Industrial Pharmacy Department, 3Clinical Pharmacy Department, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt; 4Dermatology and Andrology Department, Faculty of Medicine, Minia University, Minia, Egypt

Objective: The goal of the present study was to formulate topical nanocarriers of the low-cost vasodilator, papaverine hydrochloride (PH), as an alternative to the painful penile injections. The injections are used for both diagnosis and treatment of erectile dysfunction. Transdermal nano-transferosome (T), the ultraflexible nanoliposome, was used as a nanocarrier to enhance the penetration of the papaverine to the penis.
Methods: Different nano formulas were prepared and characterized for their encapsulation efficiency, particle size, zeta potential, and cumulative drug release. The formula acquired the best characteristics was incorporated into 2% (w/v) hydroxypropyl methylcellulose hydrogel base. The gel containing transferosomal papaverine hydrochloride (PH) and that containing free PH were clinically compared using color flow Doppler measurements.
Results: The results revealed that transferosome 3 (T3) had the highest entrapment efficiency approaching 72%, low particle size of 220 nm, and zeta potential of -33.4 mV. The formula released 73% of its initial drug content within 2 hours. The clinical evaluation showed the increase in the cavernous artery diameter from 0.53 mm to 0.78 mm and the increase in the peak systolic flow velocity from 5.95 cm/second to 12.2 cm/second, both of which were found to be significant at P<0.05.
Conclusion: It is evident from the study that the transferosomes can be used as a carrier of papaverine hydrochloride for both diagnosis and treatment of the erectile dysfunction. This new strategy could be used successfully in the treatment of erectile dysfunction and in male impotency.

Keywords: transferosomes, Color Doppler, transdermal delivery, papaverine hydro­chloride

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]

 

Readers of this article also read:

Preparation, characterization, and safety evaluation of poly(lactide-co-glycolide) nanoparticles for protein delivery into macrophages

Guedj AS, Kell AJ, Barnes M, Stals S, Gonçalves D, Girard D, Lavigne C

International Journal of Nanomedicine 2015, 10:5965-5979

Published Date: 23 September 2015

Compound antimalarial ethosomal cataplasm: preparation, evaluation, and mechanism of penetration enhancement

Shen S, Liu SZ, Zhang YS, Du MB, Liang AH, Song LH, Ye ZG

International Journal of Nanomedicine 2015, 10:4239-4253

Published Date: 30 June 2015

Chloramphenicol encapsulated in poly-ε-caprolactone–pluronic composite: nanoparticles for treatment of MRSA-infected burn wounds

Kalita S, Devi B, Kandimalla R, Sharma KK, Sharma A, Kalita K, Kataki AC, Kotoky J

International Journal of Nanomedicine 2015, 10:2971-2984

Published Date: 15 April 2015

Home-based pulmonary rehabilitation improves clinical features and systemic inflammation in chronic obstructive pulmonary disease patients

Nascimento ESP, Sampaio LMM, Peixoto-Souza FS, Dias FD, Gomes ELFD, Greiffo FR, Ligeiro de Oliveira AP, Stirbulov R, Vieira RP, Costa D

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:645-653

Published Date: 23 March 2015

Nanotechnology-based drug delivery systems for treatment of oral cancer: a review

Calixto G, Bernegossi J, Fonseca-Santos B, Chorilli M

International Journal of Nanomedicine 2014, 9:3719-3735

Published Date: 8 August 2014

Development and characterization of a novel nanoemulsion drug-delivery system for potential application in oral delivery of protein drugs

Sun H, Liu K, Liu W, Wang W, Guo C, Tang B, Gu J, Zhang J, Li H, Mao X, Zou Q, Zeng H

International Journal of Nanomedicine 2012, 7:5529-5543

Published Date: 26 October 2012

Supramolecular nanoparticles generated by the self-assembly of polyrotaxanes for antitumor drug delivery

Liu R, Lai YS, He B, Li Y, Wang G, Chang S, Gu Z

International Journal of Nanomedicine 2012, 7:5249-5258

Published Date: 5 October 2012

Multifunctional targeting micelle nanocarriers with both imaging and therapeutic potential for bladder cancer

Lin TY, Zhang H, Luo J, Li Y, Gao T, Lara Jr PN, de Vere White R, Lam KS, Pan CX

International Journal of Nanomedicine 2012, 7:2793-2804

Published Date: 6 June 2012

Anti-tumor effects of brucine immuno-nanoparticles on hepatocellular carcinoma

Qin JM, Yin PH, Li Q, Sa ZQ, Sheng X, Yang L, Huang T, Zhang M, Gao KP, Chen QH, Ma JW, Shen HB

International Journal of Nanomedicine 2012, 7:369-379

Published Date: 23 January 2012

Crystallization after intravitreal ganciclovir injection

Pitipol Choopong, Nattaporn Tesavibul, Nattawut Rodanant

Clinical Ophthalmology 2010, 4:709-711

Published Date: 14 July 2010